Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · IEX Real-Time Price · USD
13.58
-0.05 (-0.37%)
At close: Jul 19, 2024, 12:00 AM
13.53
-0.05 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Stoke Therapeutics Employees
Stoke Therapeutics had 110 employees as of December 31, 2023. The number of employees decreased by 7 or -5.98% compared to the previous year.
Employees
110
Change (1Y)
-7
Growth (1Y)
-5.98%
Revenue / Employee
$71,318
Profits / Employee
-$986,618
Market Cap
707.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Weave Communications | 844 |
Sage Therapeutics | 487 |
Lexicon Pharmaceuticals | 285 |
Zymeworks | 278 |
Wave Life Sciences | 268 |
Scholar Rock Holding | 150 |
CARGO Therapeutics | 116 |
Alumis | 109 |
STOK News
- 5 days ago - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 4 weeks ago - Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday - Benzinga
- 6 weeks ago - Stoke Therapeutics to Present at Upcoming Investor Conferences in June - Business Wire
- 2 months ago - Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates - Business Wire
- 3 months ago - Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer - Business Wire
- 3 months ago - Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer - Business Wire
- 3 months ago - Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
- 4 months ago - Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering - Business Wire